G1 Therapeutics Stock Technical Analysis
GTHXDelisted Stock | USD 7.15 0.00 0.00% |
As of the 26th of November, G1 Therapeutics owns the Market Risk Adjusted Performance of 1.01, standard deviation of 8.77, and Semi Deviation of 1.98. G1 Therapeutics technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the entity's future prices.
G1 Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as GTHX, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to GTHXGTHX |
G1 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
G1 Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
G1 Therapeutics Trend Analysis
Use this graph to draw trend lines for G1 Therapeutics. You can use it to identify possible trend reversals for G1 Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual G1 Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.G1 Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for G1 Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.11 , which means G1 Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 421.72, which is the sum of squared deviations for the predicted G1 Therapeutics price change compared to its average price change.About G1 Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of G1 Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of G1 Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on G1 Therapeutics price pattern first instead of the macroeconomic environment surrounding G1 Therapeutics. By analyzing G1 Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of G1 Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to G1 Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
G1 Therapeutics November 26, 2024 Technical Indicators
Most technical analysis of GTHX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for GTHX from various momentum indicators to cycle indicators. When you analyze GTHX charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.1497 | |||
Market Risk Adjusted Performance | 1.01 | |||
Mean Deviation | 3.77 | |||
Semi Deviation | 1.98 | |||
Downside Deviation | 3.56 | |||
Coefficient Of Variation | 543.54 | |||
Standard Deviation | 8.77 | |||
Variance | 76.95 | |||
Information Ratio | 0.1693 | |||
Jensen Alpha | 1.41 | |||
Total Risk Alpha | 0.2423 | |||
Sortino Ratio | 0.4174 | |||
Treynor Ratio | 0.9993 | |||
Maximum Drawdown | 66.4 | |||
Value At Risk | (4.12) | |||
Potential Upside | 7.59 | |||
Downside Variance | 12.66 | |||
Semi Variance | 3.91 | |||
Expected Short fall | (5.42) | |||
Skewness | 6.26 | |||
Kurtosis | 46.31 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in GTHX Stock
If you are still planning to invest in G1 Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G1 Therapeutics' history and understand the potential risks before investing.
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |